SpringWorks Therapeutics Inc. (SWTX) Announces Presentation

SpringWorks Therapeutics Inc. (SWTX) Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat

SpringWorks Therapeutics Inc. (SWTX) Announces Presentation of Additional Data from Phase 3 DeFi Trial of Nirogacestat
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , Coindre , Auvergne , United States , Denmark , American , Jim Cassidy , Kim Diamondvice , Samantha Hilson Sandler , Drug Administration , American Society Of Clinical Oncology , European Society For Medical Oncology Congress , European Commission , European Organization For Research , Fred Hutchinson Cancer Research Center , Linkedin , Nasdaq , European Consensus Initiative , Desmoid Tumor Working Group , Desmoid Working Group , Springworks Therapeutics Inc , Bone Sarcoma Group , Dana Farber Cancer Institute , Works Therapeutics , Clinical Oncology , Annual Meeting , European Society , Medical Oncology Congress , New England Journal , Chief Medical Officer , New Drug Application , Session Date , Poster Discussion , Defi Trial , Response Evaluation Criteria , Solid Tumors , Time Oncology Review , Priority Review , Prescription Drug User Fee Act , Fast Track , Breakthrough Therapy Designations , Orphan Drug Designation , Private Securities Litigation Reform Act , Springwork Quarterly Report , Diamondvice President , Investor Relations Phone , Hilson Sandler Senior Director , Gamma Secretase Inhibitor , Desmoid Working , European Organization , Soft Tissue , Mayo Clinic , Desmoid Tumors , Report Series , Rare Diseases , Desmoid Tumor Working , Springworks Therapeutics ,